For: | Español A, Salem A, Sanchez Y, Sales ME. Breast cancer: Muscarinic receptors as new targets for tumor therapy. World J Clin Oncol 2021; 12(6): 404-428 [PMID: 34189066 DOI: 10.5306/wjco.v12.i6.404] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v12/i6/404.htm |
Number | Citing Articles |
1 |
|
2 |
Joshua D. Bernstock, Jakob V. E. Gerstl, Jason A. Chen, Benjamin R. Johnston, Leo F. Nonnenbroich, Lennard Spanehl, Florian A. Gessler, Pablo A. Valdes, Yi Lu, Shriya S. Srinivasan, Timothy R. Smith, Pierpaolo Peruzzi, John D. Rolston, Scellig Stone, E. Antonio Chiocca. The Case for Neurosurgical Intervention in Cancer Neuroscience. Neurosurgery 2025; 96(1): 10 doi: 10.1227/neu.0000000000003039
|
3 |
Anastasia N. Vaganova, Daria D. Maslennikova, Valeria V. Konstantinova, Evgeny V. Kanov, Raul R. Gainetdinov. The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand–Receptor Systems and Depends on Tumor Intrinsic Subtype. Biomolecules 2023; 13(9): 1361 doi: 10.3390/biom13091361
|
4 |
Gloria M. Calaf, Leodan A. Crispin, Juan P. Muñoz, Francisco Aguayo, Tammy C. Bleak. Muscarinic Receptors Associated with Cancer. Cancers 2022; 14(9): 2322 doi: 10.3390/cancers14092322
|
5 |
Yamila Sanchez, Mariana Abigail Vasquez Callejas, Noelia Victoria Miret, Gabino Rolandelli, Catalina Costas, Andrea Silvana Randi, Alejandro Español. Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells. Exploration of Targeted Anti-tumor Therapy 2024; 5(2): 278 doi: 10.37349/etat.2024.00218
|